Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S. Krasnenko"'
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 5, Pp 631-637 (2021)
Alopecia areata (АA) is an autoimmune multifactorial disease characterized by increased hair loss as a result of morphological and functional changes in hair follicles. АA is divided into four main forms, among which the most severe is the universa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc6da409babafa3392a1232ccffb0af
https://rsp.mediar-press.net/rsp/article/view/3086
https://rsp.mediar-press.net/rsp/article/view/3086
Autor:
S. S. Krasnenko, D. A. Nedorezov, V. N. Khaidukova, Jsc Academician M. F. Reshetnev 'Information Satellite Systems'
Publikováno v:
Siberian Aerospace Journal. 22:425-431
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89a25a9b067f41ad38c2aa120fc0a10b
https://doi.org/10.31772/2712-8970-2021-22-3-425-431
https://doi.org/10.31772/2712-8970-2021-22-3-425-431
Publikováno v:
IOP Conference Series: Earth and Environmental Science. 1010:012011
The authors studied the ecological state of the ancient lakes Yantarnoe 1 and Yantarnoe 2 in the Nadym river basin. Both lakes are subject to intense anthropogenic impact, which arose during the period of oil and gas development of the Nadym lowland
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bbc35b6bbf3450d19c4a0fed0166fa3
https://doi.org/10.1088/1755-1315/1010/1/012011
https://doi.org/10.1088/1755-1315/1010/1/012011
Autor:
S. Krasnenko, A. Starkova, Shandor Erdes, E. Agafonova, M. Urumova, M. Podryadnova, D. Rumiantceva
Publikováno v:
Annals of the Rheumatic Diseases. 79:1654.2-1655
Background:Secondary AA-amyloidosis is one of the most serious complications of ankylosing spondylitis (AS). Better knowledge of specific to secondary AA-amyloidosis clinical features is important for improving further management of these patients.Ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe1b77aaf63f9866805be3c9faf2564
https://doi.org/10.1136/annrheumdis-2020-eular.3209
https://doi.org/10.1136/annrheumdis-2020-eular.3209
Autor:
O. Rumyantseva, D. Rumiantceva, S. Krasnenko, E. Gubar, Shandor Erdes, E. Agafonova, A. Demina, Tatiana Dubinina
Publikováno v:
Poster Presentations.
Background Bone loss in patients (pts) with early axial spondyloarthritis (axSpA) is insufficiently studied and may be associated with disease activity. Objectives To assess the bone mineral density (BMD) in pts with early axSpA base on data from 2 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9582e19c106e3b4ef37b0b901dc633a
https://doi.org/10.1136/annrheumdis-2017-eular.3209
https://doi.org/10.1136/annrheumdis-2017-eular.3209
Autor:
S. Krasnenko, E. Agafonova, Shandor Erdes, Tatiana Dubinina, O. Rumyantseva, D. Rumiantceva, A. Demina
Publikováno v:
Abstracts Accepted for Publication.
Background Currently non-steroidal anti-inflammatory drugs (NSAIDs) are the first-line drugs for treatment of axial spondyloarthritis (axSpA) and much discussed question of influence frequency of intake NSAIDs on axSpA disease activity. Objectives To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::512f431f08920f379975a07c6c931eca
https://doi.org/10.1136/annrheumdis-2017-eular.3646
https://doi.org/10.1136/annrheumdis-2017-eular.3646
Autor:
M. Podryadnova, O. Rumyantseva, Tatiana Dubinina, E. Agafonova, A. Starkova, M. Urumova, S. Krasnenko, A. Demina, Shandor Erdes
Publikováno v:
Annals of the Rheumatic Diseases. 75:1149.1-1149
Background Involvement of the hip joint (coxitis) is one of distinctive manifestations of ankylosing spondylitis (AS), resulting total hip arthroplasty in 5%>7% of cases. Objectives To correlate the clinical features of coxitis in AS pts with radiogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e39cba73bc849901dfa814c9073e727d
https://doi.org/10.1136/annrheumdis-2016-eular.3685
https://doi.org/10.1136/annrheumdis-2016-eular.3685
Publikováno v:
Annals of the Rheumatic Diseases. 74:1149.4-1150
Background It is deemed that production of neutralizing antibodies (ABs) is one of the key reasons for loss of infliximab (Inf) efficacy in prolonged ankylosing spondylitis (AS) therapy. Objectives To evaluate dynamic changes of Inf concentration and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::213d074fba56a9b1b56a44efbfbfe41d
https://doi.org/10.1136/annrheumdis-2015-eular.3862
https://doi.org/10.1136/annrheumdis-2015-eular.3862
Autor:
A. Demina, M. Urumova, O. Rumyantseva, E. Gubar, Shandor Erdes, S. Shubin, S. Krasnenko, Tatiana Dubinina, R. Balabanova
Publikováno v:
Annals of the Rheumatic Diseases. 74:510.2-510
Background Previous studies showed that patients with coxitis have higher disease activity and more pronounced functional impairments. Following these findings early detection of coxitis is of great clinical importance. Objectives To study the incide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d83d150e280e990fc1893abd9dbcb57
https://doi.org/10.1136/annrheumdis-2015-eular.2695
https://doi.org/10.1136/annrheumdis-2015-eular.2695
Autor:
E. Tukchova, O. Rumyantseva, S. Krasnenko, Tatiana Dubinina, Shandor Erdes, E. Gubar, A. Bochkova
Publikováno v:
Annals of the Rheumatic Diseases. 73:1021.2-1021
Background Anti-TNF therapy has been proven highly effective in patients with spondyloarthritis, but about 30% of the patients developed secondary inefficacy or adverse effects (AE). Objectives Establishing the reasons and the frequency of discontinu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b0c53a6d8c910c252943375ab08c581
https://doi.org/10.1136/annrheumdis-2014-eular.4439
https://doi.org/10.1136/annrheumdis-2014-eular.4439